# A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma

> **NCT06084962** · PHASE1 · RECRUITING · sponsor: **He Huang** · enrollment: 40 (estimated)

## Conditions studied

- Relapse/Refractory Multiple Myeloma

## Interventions

- **BIOLOGICAL:** DeepTag-GPRC5D Targeted CAR T-cells

## Key facts

- **NCT ID:** NCT06084962
- **Lead sponsor:** He Huang
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-20
- **Primary completion:** 2026-10-20
- **Final completion:** 2026-10-20
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06084962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06084962, "A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06084962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*